nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—CYP2D6—Hydroxyurea—head and neck cancer	0.284	0.739	CbGbCtD
Dexmethylphenidate—CYP2D6—Vinblastine—head and neck cancer	0.1	0.261	CbGbCtD
Dexmethylphenidate—Pancytopenia—Vinblastine—head and neck cancer	0.00302	0.00491	CcSEcCtD
Dexmethylphenidate—Euphoric mood—Fluorouracil—head and neck cancer	0.00286	0.00465	CcSEcCtD
Dexmethylphenidate—Pancreatitis—Hydroxyurea—head and neck cancer	0.00285	0.00462	CcSEcCtD
Dexmethylphenidate—Depression—Vinblastine—head and neck cancer	0.00283	0.0046	CcSEcCtD
Dexmethylphenidate—Acute coronary syndrome—Vinblastine—head and neck cancer	0.0028	0.00454	CcSEcCtD
Dexmethylphenidate—Myocardial infarction—Vinblastine—head and neck cancer	0.00278	0.00452	CcSEcCtD
Dexmethylphenidate—Pancytopenia—Hydroxyurea—head and neck cancer	0.00276	0.00448	CcSEcCtD
Dexmethylphenidate—Photosensitivity—Fluorouracil—head and neck cancer	0.00275	0.00447	CcSEcCtD
Dexmethylphenidate—Swelling—Fluorouracil—head and neck cancer	0.00274	0.00445	CcSEcCtD
Dexmethylphenidate—Chest discomfort—Docetaxel—head and neck cancer	0.00272	0.00441	CcSEcCtD
Dexmethylphenidate—Disorientation—Fluorouracil—head and neck cancer	0.0027	0.00439	CcSEcCtD
Dexmethylphenidate—Bone disorder—Docetaxel—head and neck cancer	0.00266	0.00432	CcSEcCtD
Dexmethylphenidate—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00264	0.00429	CcSEcCtD
Dexmethylphenidate—Weight increased—Hydroxyurea—head and neck cancer	0.00264	0.00429	CcSEcCtD
Dexmethylphenidate—Drug interaction—Docetaxel—head and neck cancer	0.00259	0.00421	CcSEcCtD
Dexmethylphenidate—Infestation NOS—Hydroxyurea—head and neck cancer	0.00259	0.0042	CcSEcCtD
Dexmethylphenidate—Infestation—Hydroxyurea—head and neck cancer	0.00259	0.0042	CcSEcCtD
Dexmethylphenidate—Drowsiness—Hydroxyurea—head and neck cancer	0.00259	0.0042	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Vinblastine—head and neck cancer	0.00256	0.00416	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Vinblastine—head and neck cancer	0.00255	0.00414	CcSEcCtD
Dexmethylphenidate—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00254	0.00413	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Vinblastine—head and neck cancer	0.00253	0.00411	CcSEcCtD
Dexmethylphenidate—Inflammation—Docetaxel—head and neck cancer	0.00248	0.00402	CcSEcCtD
Dexmethylphenidate—Lethargy—Fluorouracil—head and neck cancer	0.00247	0.00401	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00245	0.00398	CcSEcCtD
Dexmethylphenidate—Blood pressure increased—Docetaxel—head and neck cancer	0.0024	0.0039	CcSEcCtD
Dexmethylphenidate—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.0024	0.0039	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Hydroxyurea—head and neck cancer	0.00234	0.00379	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Hydroxyurea—head and neck cancer	0.00232	0.00377	CcSEcCtD
Dexmethylphenidate—Hallucination—Hydroxyurea—head and neck cancer	0.00231	0.00375	CcSEcCtD
Dexmethylphenidate—Irritability—Fluorouracil—head and neck cancer	0.00231	0.00375	CcSEcCtD
Dexmethylphenidate—Cardiac arrest—Fluorouracil—head and neck cancer	0.0023	0.00373	CcSEcCtD
Dexmethylphenidate—Skin exfoliation—Docetaxel—head and neck cancer	0.0023	0.00373	CcSEcCtD
Dexmethylphenidate—Alopecia—Vinblastine—head and neck cancer	0.00225	0.00366	CcSEcCtD
Dexmethylphenidate—Neoplasm—Docetaxel—head and neck cancer	0.00217	0.00353	CcSEcCtD
Dexmethylphenidate—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00216	0.00351	CcSEcCtD
Dexmethylphenidate—Angiopathy—Hydroxyurea—head and neck cancer	0.00211	0.00342	CcSEcCtD
Dexmethylphenidate—Chills—Hydroxyurea—head and neck cancer	0.00209	0.00339	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Vinblastine—head and neck cancer	0.00206	0.00334	CcSEcCtD
Dexmethylphenidate—Alopecia—Hydroxyurea—head and neck cancer	0.00205	0.00333	CcSEcCtD
Dexmethylphenidate—Anaemia—Vinblastine—head and neck cancer	0.00205	0.00333	CcSEcCtD
Dexmethylphenidate—Angina pectoris—Fluorouracil—head and neck cancer	0.00204	0.00331	CcSEcCtD
Dexmethylphenidate—Erythema—Hydroxyurea—head and neck cancer	0.00202	0.00328	CcSEcCtD
Dexmethylphenidate—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00201	0.00326	CcSEcCtD
Dexmethylphenidate—Malaise—Vinblastine—head and neck cancer	0.002	0.00325	CcSEcCtD
Dexmethylphenidate—Vertigo—Vinblastine—head and neck cancer	0.00199	0.00324	CcSEcCtD
Dexmethylphenidate—Leukopenia—Vinblastine—head and neck cancer	0.00199	0.00322	CcSEcCtD
Dexmethylphenidate—Pancytopenia—Fluorouracil—head and neck cancer	0.00199	0.00322	CcSEcCtD
Dexmethylphenidate—Swelling—Docetaxel—head and neck cancer	0.00198	0.00321	CcSEcCtD
Dexmethylphenidate—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00194	0.00315	CcSEcCtD
Dexmethylphenidate—Convulsion—Vinblastine—head and neck cancer	0.00192	0.00312	CcSEcCtD
Dexmethylphenidate—Hypertension—Vinblastine—head and neck cancer	0.00192	0.00311	CcSEcCtD
Dexmethylphenidate—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00191	0.0031	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00188	0.00305	CcSEcCtD
Dexmethylphenidate—Pneumonia—Fluorouracil—head and neck cancer	0.00187	0.00304	CcSEcCtD
Dexmethylphenidate—Anaemia—Hydroxyurea—head and neck cancer	0.00187	0.00304	CcSEcCtD
Dexmethylphenidate—Discomfort—Vinblastine—head and neck cancer	0.00187	0.00303	CcSEcCtD
Dexmethylphenidate—Hot flush—Docetaxel—head and neck cancer	0.00187	0.00303	CcSEcCtD
Dexmethylphenidate—Infestation NOS—Fluorouracil—head and neck cancer	0.00186	0.00303	CcSEcCtD
Dexmethylphenidate—Infestation—Fluorouracil—head and neck cancer	0.00186	0.00303	CcSEcCtD
Dexmethylphenidate—Menopausal symptoms—Docetaxel—head and neck cancer	0.00185	0.003	CcSEcCtD
Dexmethylphenidate—Visual disturbance—Docetaxel—head and neck cancer	0.00184	0.00299	CcSEcCtD
Dexmethylphenidate—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00184	0.00298	CcSEcCtD
Dexmethylphenidate—Myocardial infarction—Fluorouracil—head and neck cancer	0.00183	0.00297	CcSEcCtD
Dexmethylphenidate—Malaise—Hydroxyurea—head and neck cancer	0.00182	0.00296	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Fluorouracil—head and neck cancer	0.00181	0.00294	CcSEcCtD
Dexmethylphenidate—Leukopenia—Hydroxyurea—head and neck cancer	0.00181	0.00294	CcSEcCtD
Dexmethylphenidate—Lethargy—Docetaxel—head and neck cancer	0.00178	0.00289	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Vinblastine—head and neck cancer	0.00177	0.00288	CcSEcCtD
Dexmethylphenidate—Epistaxis—Fluorouracil—head and neck cancer	0.00176	0.00285	CcSEcCtD
Dexmethylphenidate—Convulsion—Hydroxyurea—head and neck cancer	0.00175	0.00285	CcSEcCtD
Dexmethylphenidate—Sinusitis—Fluorouracil—head and neck cancer	0.00175	0.00284	CcSEcCtD
Dexmethylphenidate—Pain in extremity—Docetaxel—head and neck cancer	0.00175	0.00283	CcSEcCtD
Dexmethylphenidate—Anorexia—Vinblastine—head and neck cancer	0.00173	0.0028	CcSEcCtD
Dexmethylphenidate—Migraine—Docetaxel—head and neck cancer	0.00172	0.00279	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00171	0.00278	CcSEcCtD
Dexmethylphenidate—Discomfort—Hydroxyurea—head and neck cancer	0.0017	0.00276	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Fluorouracil—head and neck cancer	0.00168	0.00273	CcSEcCtD
Dexmethylphenidate—Rhinitis—Fluorouracil—head and neck cancer	0.00168	0.00272	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Fluorouracil—head and neck cancer	0.00167	0.00272	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Fluorouracil—head and neck cancer	0.00166	0.0027	CcSEcCtD
Dexmethylphenidate—Oedema—Hydroxyurea—head and neck cancer	0.00165	0.00268	CcSEcCtD
Dexmethylphenidate—Infection—Hydroxyurea—head and neck cancer	0.00164	0.00266	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Vinblastine—head and neck cancer	0.00163	0.00264	CcSEcCtD
Dexmethylphenidate—Dehydration—Docetaxel—head and neck cancer	0.00162	0.00264	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00162	0.00263	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00162	0.00262	CcSEcCtD
Dexmethylphenidate—Liver function test abnormal—Docetaxel—head and neck cancer	0.00161	0.00262	CcSEcCtD
Dexmethylphenidate—Skin disorder—Hydroxyurea—head and neck cancer	0.0016	0.0026	CcSEcCtD
Dexmethylphenidate—Abdominal pain upper—Docetaxel—head and neck cancer	0.00159	0.00259	CcSEcCtD
Dexmethylphenidate—Breast disorder—Docetaxel—head and neck cancer	0.00158	0.00256	CcSEcCtD
Dexmethylphenidate—Anorexia—Hydroxyurea—head and neck cancer	0.00157	0.00256	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Vinblastine—head and neck cancer	0.00157	0.00256	CcSEcCtD
Dexmethylphenidate—Cramp muscle—Docetaxel—head and neck cancer	0.00157	0.00255	CcSEcCtD
Dexmethylphenidate—Nasopharyngitis—Docetaxel—head and neck cancer	0.00156	0.00253	CcSEcCtD
Dexmethylphenidate—Pain—Vinblastine—head and neck cancer	0.00155	0.00251	CcSEcCtD
Dexmethylphenidate—Constipation—Vinblastine—head and neck cancer	0.00155	0.00251	CcSEcCtD
Dexmethylphenidate—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00154	0.0025	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Fluorouracil—head and neck cancer	0.00149	0.00243	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Vinblastine—head and neck cancer	0.00149	0.00242	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00148	0.0024	CcSEcCtD
Dexmethylphenidate—Alopecia—Fluorouracil—head and neck cancer	0.00148	0.0024	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Hydroxyurea—head and neck cancer	0.00147	0.00239	CcSEcCtD
Dexmethylphenidate—Angina pectoris—Docetaxel—head and neck cancer	0.00147	0.00239	CcSEcCtD
Dexmethylphenidate—Somnolence—Hydroxyurea—head and neck cancer	0.00147	0.00238	CcSEcCtD
Dexmethylphenidate—Erythema—Fluorouracil—head and neck cancer	0.00146	0.00236	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Hydroxyurea—head and neck cancer	0.00145	0.00236	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Hydroxyurea—head and neck cancer	0.00144	0.00233	CcSEcCtD
Dexmethylphenidate—Pancytopenia—Docetaxel—head and neck cancer	0.00143	0.00233	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Vinblastine—head and neck cancer	0.00143	0.00232	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00143	0.00231	CcSEcCtD
Dexmethylphenidate—Fatigue—Hydroxyurea—head and neck cancer	0.00142	0.00231	CcSEcCtD
Dexmethylphenidate—Pain—Hydroxyurea—head and neck cancer	0.00141	0.00229	CcSEcCtD
Dexmethylphenidate—Constipation—Hydroxyurea—head and neck cancer	0.00141	0.00229	CcSEcCtD
Dexmethylphenidate—Weight increased—Docetaxel—head and neck cancer	0.00137	0.00223	CcSEcCtD
Dexmethylphenidate—Vision blurred—Fluorouracil—head and neck cancer	0.00137	0.00223	CcSEcCtD
Dexmethylphenidate—Weight decreased—Docetaxel—head and neck cancer	0.00136	0.00222	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00136	0.00221	CcSEcCtD
Dexmethylphenidate—Pneumonia—Docetaxel—head and neck cancer	0.00135	0.0022	CcSEcCtD
Dexmethylphenidate—Anaemia—Fluorouracil—head and neck cancer	0.00135	0.00219	CcSEcCtD
Dexmethylphenidate—Infestation NOS—Docetaxel—head and neck cancer	0.00135	0.00218	CcSEcCtD
Dexmethylphenidate—Infestation—Docetaxel—head and neck cancer	0.00135	0.00218	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Vinblastine—head and neck cancer	0.00133	0.00217	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00133	0.00217	CcSEcCtD
Dexmethylphenidate—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00133	0.00215	CcSEcCtD
Dexmethylphenidate—Myocardial infarction—Docetaxel—head and neck cancer	0.00132	0.00214	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Docetaxel—head and neck cancer	0.00131	0.00212	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Hydroxyurea—head and neck cancer	0.00131	0.00212	CcSEcCtD
Dexmethylphenidate—Leukopenia—Fluorouracil—head and neck cancer	0.0013	0.00212	CcSEcCtD
Dexmethylphenidate—Asthenia—Vinblastine—head and neck cancer	0.0013	0.00211	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00127	0.00207	CcSEcCtD
Dexmethylphenidate—Epistaxis—Docetaxel—head and neck cancer	0.00127	0.00206	CcSEcCtD
Dexmethylphenidate—Convulsion—Fluorouracil—head and neck cancer	0.00126	0.00205	CcSEcCtD
Dexmethylphenidate—Chest pain—Fluorouracil—head and neck cancer	0.00124	0.00201	CcSEcCtD
Dexmethylphenidate—Myalgia—Fluorouracil—head and neck cancer	0.00124	0.00201	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Vinblastine—head and neck cancer	0.00124	0.00201	CcSEcCtD
Dexmethylphenidate—Discomfort—Fluorouracil—head and neck cancer	0.00123	0.00199	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00122	0.00198	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Docetaxel—head and neck cancer	0.00121	0.00197	CcSEcCtD
Dexmethylphenidate—Rhinitis—Docetaxel—head and neck cancer	0.00121	0.00197	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Docetaxel—head and neck cancer	0.00121	0.00196	CcSEcCtD
Dexmethylphenidate—Confusional state—Fluorouracil—head and neck cancer	0.0012	0.00195	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Docetaxel—head and neck cancer	0.0012	0.00195	CcSEcCtD
Dexmethylphenidate—Dizziness—Vinblastine—head and neck cancer	0.0012	0.00194	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Docetaxel—head and neck cancer	0.00119	0.00194	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00119	0.00193	CcSEcCtD
Dexmethylphenidate—Oedema—Fluorouracil—head and neck cancer	0.00119	0.00193	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Docetaxel—head and neck cancer	0.00119	0.00193	CcSEcCtD
Dexmethylphenidate—Asthenia—Hydroxyurea—head and neck cancer	0.00118	0.00192	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Docetaxel—head and neck cancer	0.00118	0.00192	CcSEcCtD
Dexmethylphenidate—Infection—Fluorouracil—head and neck cancer	0.00118	0.00192	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Fluorouracil—head and neck cancer	0.00117	0.00189	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00116	0.00189	CcSEcCtD
Dexmethylphenidate—Visual impairment—Docetaxel—head and neck cancer	0.00116	0.00189	CcSEcCtD
Dexmethylphenidate—Tachycardia—Fluorouracil—head and neck cancer	0.00116	0.00188	CcSEcCtD
Dexmethylphenidate—Vomiting—Vinblastine—head and neck cancer	0.00115	0.00187	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Docetaxel—head and neck cancer	0.00114	0.00185	CcSEcCtD
Dexmethylphenidate—Headache—Vinblastine—head and neck cancer	0.00113	0.00184	CcSEcCtD
Dexmethylphenidate—Anorexia—Fluorouracil—head and neck cancer	0.00113	0.00184	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Hydroxyurea—head and neck cancer	0.00113	0.00183	CcSEcCtD
Dexmethylphenidate—Eye disorder—Docetaxel—head and neck cancer	0.00113	0.00183	CcSEcCtD
Dexmethylphenidate—Flushing—Docetaxel—head and neck cancer	0.00112	0.00182	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Docetaxel—head and neck cancer	0.00112	0.00182	CcSEcCtD
Dexmethylphenidate—Angiopathy—Docetaxel—head and neck cancer	0.0011	0.00178	CcSEcCtD
Dexmethylphenidate—Dizziness—Hydroxyurea—head and neck cancer	0.00109	0.00177	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Docetaxel—head and neck cancer	0.00109	0.00177	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Docetaxel—head and neck cancer	0.00109	0.00177	CcSEcCtD
Dexmethylphenidate—Chills—Docetaxel—head and neck cancer	0.00108	0.00176	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00108	0.00176	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Docetaxel—head and neck cancer	0.00108	0.00175	CcSEcCtD
Dexmethylphenidate—Nausea—Vinblastine—head and neck cancer	0.00108	0.00175	CcSEcCtD
Dexmethylphenidate—Insomnia—Fluorouracil—head and neck cancer	0.00108	0.00175	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Fluorouracil—head and neck cancer	0.00107	0.00173	CcSEcCtD
Dexmethylphenidate—Alopecia—Docetaxel—head and neck cancer	0.00107	0.00173	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Fluorouracil—head and neck cancer	0.00106	0.00172	CcSEcCtD
Dexmethylphenidate—Mental disorder—Docetaxel—head and neck cancer	0.00106	0.00172	CcSEcCtD
Dexmethylphenidate—Somnolence—Fluorouracil—head and neck cancer	0.00106	0.00172	CcSEcCtD
Dexmethylphenidate—Erythema—Docetaxel—head and neck cancer	0.00105	0.00171	CcSEcCtD
Dexmethylphenidate—Malnutrition—Docetaxel—head and neck cancer	0.00105	0.00171	CcSEcCtD
Dexmethylphenidate—Vomiting—Hydroxyurea—head and neck cancer	0.00105	0.0017	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Fluorouracil—head and neck cancer	0.00105	0.0017	CcSEcCtD
Dexmethylphenidate—Rash—Hydroxyurea—head and neck cancer	0.00104	0.00169	CcSEcCtD
Dexmethylphenidate—Dermatitis—Hydroxyurea—head and neck cancer	0.00104	0.00169	CcSEcCtD
Dexmethylphenidate—Headache—Hydroxyurea—head and neck cancer	0.00103	0.00168	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Fluorouracil—head and neck cancer	0.00103	0.00168	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00103	0.00167	CcSEcCtD
Dexmethylphenidate—Back pain—Docetaxel—head and neck cancer	0.00102	0.00165	CcSEcCtD
Dexmethylphenidate—Pain—Fluorouracil—head and neck cancer	0.00102	0.00165	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Docetaxel—head and neck cancer	0.00101	0.00164	CcSEcCtD
Dexmethylphenidate—Nausea—Hydroxyurea—head and neck cancer	0.000981	0.00159	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Fluorouracil—head and neck cancer	0.00098	0.00159	CcSEcCtD
Dexmethylphenidate—Anaemia—Docetaxel—head and neck cancer	0.000972	0.00158	CcSEcCtD
Dexmethylphenidate—Urticaria—Fluorouracil—head and neck cancer	0.000944	0.00153	CcSEcCtD
Dexmethylphenidate—Syncope—Docetaxel—head and neck cancer	0.000943	0.00153	CcSEcCtD
Dexmethylphenidate—Leukopenia—Docetaxel—head and neck cancer	0.000941	0.00153	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Fluorouracil—head and neck cancer	0.00094	0.00153	CcSEcCtD
Dexmethylphenidate—Palpitations—Docetaxel—head and neck cancer	0.000929	0.00151	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Docetaxel—head and neck cancer	0.000924	0.0015	CcSEcCtD
Dexmethylphenidate—Cough—Docetaxel—head and neck cancer	0.000917	0.00149	CcSEcCtD
Dexmethylphenidate—Convulsion—Docetaxel—head and neck cancer	0.000911	0.00148	CcSEcCtD
Dexmethylphenidate—Hypertension—Docetaxel—head and neck cancer	0.000908	0.00147	CcSEcCtD
Dexmethylphenidate—Arthralgia—Docetaxel—head and neck cancer	0.000895	0.00145	CcSEcCtD
Dexmethylphenidate—Chest pain—Docetaxel—head and neck cancer	0.000895	0.00145	CcSEcCtD
Dexmethylphenidate—Myalgia—Docetaxel—head and neck cancer	0.000895	0.00145	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000889	0.00144	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Fluorouracil—head and neck cancer	0.000876	0.00142	CcSEcCtD
Dexmethylphenidate—Dry mouth—Docetaxel—head and neck cancer	0.000875	0.00142	CcSEcCtD
Dexmethylphenidate—Confusional state—Docetaxel—head and neck cancer	0.000865	0.0014	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Docetaxel—head and neck cancer	0.000858	0.00139	CcSEcCtD
Dexmethylphenidate—Oedema—Docetaxel—head and neck cancer	0.000858	0.00139	CcSEcCtD
Dexmethylphenidate—Infection—Docetaxel—head and neck cancer	0.000852	0.00138	CcSEcCtD
Dexmethylphenidate—Shock—Docetaxel—head and neck cancer	0.000844	0.00137	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Docetaxel—head and neck cancer	0.000841	0.00137	CcSEcCtD
Dexmethylphenidate—Pruritus—Fluorouracil—head and neck cancer	0.000841	0.00137	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Docetaxel—head and neck cancer	0.00084	0.00136	CcSEcCtD
Dexmethylphenidate—Tachycardia—Docetaxel—head and neck cancer	0.000837	0.00136	CcSEcCtD
Dexmethylphenidate—Skin disorder—Docetaxel—head and neck cancer	0.000833	0.00135	CcSEcCtD
Dexmethylphenidate—Anorexia—Docetaxel—head and neck cancer	0.000818	0.00133	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Fluorouracil—head and neck cancer	0.000813	0.00132	CcSEcCtD
Dexmethylphenidate—Dizziness—Fluorouracil—head and neck cancer	0.000786	0.00128	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000782	0.00127	CcSEcCtD
Dexmethylphenidate—Insomnia—Docetaxel—head and neck cancer	0.000776	0.00126	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Docetaxel—head and neck cancer	0.00077	0.00125	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Docetaxel—head and neck cancer	0.000765	0.00124	CcSEcCtD
Dexmethylphenidate—Somnolence—Docetaxel—head and neck cancer	0.000763	0.00124	CcSEcCtD
Dexmethylphenidate—Vomiting—Fluorouracil—head and neck cancer	0.000756	0.00123	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Docetaxel—head and neck cancer	0.000755	0.00123	CcSEcCtD
Dexmethylphenidate—Rash—Fluorouracil—head and neck cancer	0.00075	0.00122	CcSEcCtD
Dexmethylphenidate—Dermatitis—Fluorouracil—head and neck cancer	0.000749	0.00122	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Docetaxel—head and neck cancer	0.000746	0.00121	CcSEcCtD
Dexmethylphenidate—Headache—Fluorouracil—head and neck cancer	0.000745	0.00121	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000741	0.0012	CcSEcCtD
Dexmethylphenidate—Fatigue—Docetaxel—head and neck cancer	0.00074	0.0012	CcSEcCtD
Dexmethylphenidate—Pain—Docetaxel—head and neck cancer	0.000734	0.00119	CcSEcCtD
Dexmethylphenidate—Constipation—Docetaxel—head and neck cancer	0.000734	0.00119	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Docetaxel—head and neck cancer	0.000707	0.00115	CcSEcCtD
Dexmethylphenidate—Nausea—Fluorouracil—head and neck cancer	0.000706	0.00115	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000702	0.00114	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Docetaxel—head and neck cancer	0.000678	0.0011	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Docetaxel—head and neck cancer	0.000678	0.0011	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Docetaxel—head and neck cancer	0.000632	0.00103	CcSEcCtD
Dexmethylphenidate—Asthenia—Docetaxel—head and neck cancer	0.000616	0.000999	CcSEcCtD
Dexmethylphenidate—Pruritus—Docetaxel—head and neck cancer	0.000607	0.000985	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Docetaxel—head and neck cancer	0.000587	0.000953	CcSEcCtD
Dexmethylphenidate—Dizziness—Docetaxel—head and neck cancer	0.000567	0.000921	CcSEcCtD
Dexmethylphenidate—Vomiting—Docetaxel—head and neck cancer	0.000546	0.000886	CcSEcCtD
Dexmethylphenidate—Rash—Docetaxel—head and neck cancer	0.000541	0.000878	CcSEcCtD
Dexmethylphenidate—Dermatitis—Docetaxel—head and neck cancer	0.00054	0.000877	CcSEcCtD
Dexmethylphenidate—Headache—Docetaxel—head and neck cancer	0.000537	0.000873	CcSEcCtD
Dexmethylphenidate—Nausea—Docetaxel—head and neck cancer	0.00051	0.000827	CcSEcCtD
